FDA seeks more safety data on Vioxx successor Merck  amp; Co. said the US Food and Drug Administration has requested additional safety and efficacy information on its Vioxx successor, Arcoxia, before it considers granting US approval for the drug. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 